(-0.46%) 5 026.00 points
(-0.28%) 37 900 points
(-0.65%) 17 434 points
(-1.05%) $81.86
(-0.68%) $1.745
(-0.42%) $2 388.00
(-0.63%) $28.20
(-1.45%) $940.70
(-0.01%) $0.939
(0.09%) $11.05
(0.04%) $0.804
(-0.72%) $93.23
@ $89.64
Issued: 18 Apr 2024 @ 12:45
Return: -2.63%
Previous signal: Apr 17 - 13:55
Previous signal:
Return: -0.70 %
Live Chart Being Loaded With Signals
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify single-gene disorder; Horizon carrier screening to determine carrier status for various genetic diseases; and Spectrum to identify chromosomal anomalies or inherited genetic conditions during an in vitro fertilization cycle...
Stats | |
---|---|
Today's Volume | 959 946 |
Average Volume | 1.43M |
Market Cap | 10.40B |
EPS | $0 ( 2024-02-28 ) |
Next earnings date | ( $-0.700 ) 2024-05-07 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -19.53 |
ATR14 | $2.95 (3.38%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-16 | Moshkevich Solomon | Sell | 26 511 | Common Stock |
2024-04-16 | Moshkevich Solomon | Sell | 53 489 | Common Stock |
2024-04-15 | Chapman Steven Leonard | Sell | 4 305 | Common Stock |
2024-04-15 | Chapman Steven Leonard | Sell | 2 411 | Common Stock |
2024-04-15 | Chapman Steven Leonard | Sell | 100 | Common Stock |
INSIDER POWER |
---|
-14.06 |
Last 100 transactions |
Buy: 619 763 | Sell: 806 900 |
Volume Correlation
Natera Inc Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Natera Inc Correlation - Currency/Commodity
Natera Inc Financials
Annual | 2023 |
Revenue: | $1.08B |
Gross Profit: | $492.74M (45.52 %) |
EPS: | $-3.78 |
Q4 | 2023 |
Revenue: | $311.11M |
Gross Profit: | $159.86M (51.38 %) |
EPS: | $-0.650 |
Q3 | 2023 |
Revenue: | $268.31M |
Gross Profit: | $121.00M (45.10 %) |
EPS: | $-0.950 |
Q2 | 2023 |
Revenue: | $261.40M |
Gross Profit: | $118.26M (45.24 %) |
EPS: | $-0.970 |
Financial Reports:
No articles found.
Natera Inc
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify single-gene disorder; Horizon carrier screening to determine carrier status for various genetic diseases; and Spectrum to identify chromosomal anomalies or inherited genetic conditions during an in vitro fertilization cycle. The company also provides Anora miscarriage test products to analyze fetal chromosomes to understand the cause of miscarriage; and non-invasive paternity testing products to determine paternity by gestation using a blood draw from the pregnant mother and alleged father. In addition, it offers Constellation, a cloud-based software product that enables laboratory customers to gain access through the cloud to the company's algorithms and bioinformatics in order to validate and launch tests; Signatera, a circulating tumor DNA technology that screen for a generic set of mutations independent of an individual's tumor; and Prospera used to assess organ transplant rejection. The company offers products through its direct sales force, as well as through a network of approximately 100 laboratory and distribution partners. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays; and Foundation Medicine, Inc. to develop and commercialize personalized circulating tumor DNA monitoring assays. The company was formerly known as Gene Security Network, Inc. and changed its name to Natera, Inc. in 2012. Natera, Inc. was founded in 2003 and is based in Austin, Texas.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators